Felker v. Teva Branded Pharmaceutical Products R
| Jurisdiction | British Columbia |
| Court | Supreme Court of British Columbia (Canada) |
| Judge | Douglas |
| Citation | 2022 BCSC 1813 |
| Date | 17 October 2022 |
| Docket Number | S205093 |
Get this document and AI-powered insights with a free trial of vLex and Vincent AI
Get Started for FreeUnlock full access with a free 7-day trial
Transform your legal research with vLex
-
Complete access to the largest collection of common law case law on one platform
-
Generate AI case summaries that instantly highlight key legal issues
-
Advanced search capabilities with precise filtering and sorting options
-
Comprehensive legal content with documents across 100+ jurisdictions
-
Trusted by 2 million professionals including top global firms
-
Access AI-Powered Research with Vincent AI: Natural language queries with verified citations
Unlock full access with a free 7-day trial
Transform your legal research with vLex
-
Complete access to the largest collection of common law case law on one platform
-
Generate AI case summaries that instantly highlight key legal issues
-
Advanced search capabilities with precise filtering and sorting options
-
Comprehensive legal content with documents across 100+ jurisdictions
-
Trusted by 2 million professionals including top global firms
-
Access AI-Powered Research with Vincent AI: Natural language queries with verified citations
Unlock full access with a free 7-day trial
Transform your legal research with vLex
-
Complete access to the largest collection of common law case law on one platform
-
Generate AI case summaries that instantly highlight key legal issues
-
Advanced search capabilities with precise filtering and sorting options
-
Comprehensive legal content with documents across 100+ jurisdictions
-
Trusted by 2 million professionals including top global firms
-
Access AI-Powered Research with Vincent AI: Natural language queries with verified citations
Unlock full access with a free 7-day trial
Transform your legal research with vLex
-
Complete access to the largest collection of common law case law on one platform
-
Generate AI case summaries that instantly highlight key legal issues
-
Advanced search capabilities with precise filtering and sorting options
-
Comprehensive legal content with documents across 100+ jurisdictions
-
Trusted by 2 million professionals including top global firms
-
Access AI-Powered Research with Vincent AI: Natural language queries with verified citations
Unlock full access with a free 7-day trial
Transform your legal research with vLex
-
Complete access to the largest collection of common law case law on one platform
-
Generate AI case summaries that instantly highlight key legal issues
-
Advanced search capabilities with precise filtering and sorting options
-
Comprehensive legal content with documents across 100+ jurisdictions
-
Trusted by 2 million professionals including top global firms
-
Access AI-Powered Research with Vincent AI: Natural language queries with verified citations
Start Your 7-day Trial
6 practice notes
-
Gionet v Syngenta
...other grounds 2022 BCCA 151; Miller BCCA at paras. 54–66; Stanway BCCA at paras. 40–47; Felker v. Teva Branded Pharmaceutical Products R, 2022 BCSC 1813 at paras. 213–219; Bartram v. GlaxoSmithKline Inc., 2013 BCCA 462 at para. The evidentiary record and “some basis in fact” 152 The “genera......
-
Bosco v Mentor Worldwide LLC
...are admissible as some basis in fact for assessing the certification criteria, citing Felker v. Teva Branded Pharmaceutical Products R, 2022 BCSC 1813 at paras. 94 – 100. He describes Mentor's objections regarding the reliability of these hair element analyses as merits-based and irrelevant......
-
Mentor Worldwide LLC v Bosco
...be said of the appellants' related argument based on the certification decision in Felker v. Teva Branded Pharmaceutical Products R, 2022 BCSC 1813 [ Felker]. In Felker, the plaintiffs sought to certify a class action involving a prescription drug that was alleged to cause users to dev......
-
I.F. v Gilead Sciences, Inc.
...has been found to be appropriate for certification in similar cases (see, for example: Felker v. Teva Branded Pharmaceutical Products R, 2022 BCSC 1813 at paras. 91 In this case, however, Gilead concedes that it owes a duty of care to the class members. There is jurisprudential authority fo......
Get Started for Free
